TW206231B - - Google Patents

Download PDF

Info

Publication number
TW206231B
TW206231B TW078102489A TW78102489A TW206231B TW 206231 B TW206231 B TW 206231B TW 078102489 A TW078102489 A TW 078102489A TW 78102489 A TW78102489 A TW 78102489A TW 206231 B TW206231 B TW 206231B
Authority
TW
Taiwan
Prior art keywords
complex
shows
compound
heart
centripetal
Prior art date
Application number
TW078102489A
Other languages
English (en)
Chinese (zh)
Original Assignee
Amersham Internat Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10634927&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW206231(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amersham Internat Plc filed Critical Amersham Internat Plc
Application granted granted Critical
Publication of TW206231B publication Critical patent/TW206231B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165—Esters of thiophosphoric acids
    • C07F9/20—Esters of thiophosphoric acids containing P-halide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/5027—Polyphosphines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
TW078102489A 1988-04-11 1989-04-01 TW206231B (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888808414A GB8808414D0 (en) 1988-04-11 1988-04-11 Ligands & cationic complexes thereof with technetium-99m

Publications (1)

Publication Number Publication Date
TW206231B true TW206231B (https=) 1993-05-21

Family

ID=10634927

Family Applications (1)

Application Number Title Priority Date Filing Date
TW078102489A TW206231B (https=) 1988-04-11 1989-04-01

Country Status (14)

Country Link
US (1) US5045302A (https=)
EP (1) EP0337654B1 (https=)
JP (2) JP2690142B2 (https=)
KR (1) KR0149439B1 (https=)
CN (2) CN1022633C (https=)
AT (1) ATE133956T1 (https=)
CA (1) CA1336437C (https=)
DE (1) DE68925594T2 (https=)
DK (1) DK171416B1 (https=)
ES (1) ES2082771T3 (https=)
GB (1) GB8808414D0 (https=)
HK (1) HK98097A (https=)
IL (1) IL89779A (https=)
TW (1) TW206231B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD291327A5 (de) * 1989-12-29 1991-06-27 �������@����@�K@��@��k�� Myokardgaengige technetium-komplexverbindungen und verfahren zu deren herstellung
US5338864A (en) * 1992-07-06 1994-08-16 Mallinckrodt Medical, Inc. Hexadentate ligands useful in radiographic imaging agents
US5750088A (en) * 1993-03-30 1998-05-12 The Dupont Merck Pharmaceutical Company Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
US5744120A (en) * 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
US7575653B2 (en) * 1993-04-15 2009-08-18 3M Innovative Properties Company Melt-flowable materials and method of sealing surfaces
WO1996030056A1 (en) * 1995-03-29 1996-10-03 The Curators Of The University Of Missouri Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
EP1117668B1 (en) * 1998-09-30 2002-12-11 Atofina Vlissingen B.V. Fluorous phosphines and process for their preparation
GB0427392D0 (en) * 2004-12-15 2005-01-19 Amersham Plc Stabilised 99mTc compositions
JP4863345B2 (ja) * 2005-03-18 2012-01-25 国立大学法人金沢大学 心筋用放射性画像診断剤又は放射性治療薬
CA2654369C (en) * 2006-06-21 2014-10-14 Ge Healthcare Limited Radiopharmaceutical products
JP5427483B2 (ja) * 2009-06-19 2014-02-26 株式会社化研 放射性医薬品およびその標識化合物原料としての放射性テクネチウムの濃縮および溶出回収方法、およびシステム
US9321095B2 (en) 2010-06-30 2016-04-26 General Electric Company Apparatuses and methods for cutting porous substrates
EP2899195A1 (en) 2014-01-28 2015-07-29 ROTOP Pharmaka AG Stabilized form of Tetrofosmin and its use
KR20190128545A (ko) * 2017-03-08 2019-11-18 주빌런트 제네릭스 리미티드(포멀리 어 디비젼 오브 주빌런트 라이프 사이언시스 리미티드) 테트로포스민 또는 그것의 산 부가 염의 제조를 위한 개선된 과정

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1917884A1 (de) * 1968-04-08 1969-10-16 Toa Gosei Chem Ind Verfahren zur Herstellung von 1-Buten-2,3,4-tricarbonsaeureestern
US4451450A (en) * 1981-10-15 1984-05-29 New England Nuclear Corporation Cationic compounds useful for making radiodiagnostic agents
US4481184A (en) * 1983-02-14 1984-11-06 E. R. Squibb & Sons, Inc. Cationic technetium (I) complexes
US4526776A (en) * 1983-04-15 1985-07-02 E. I. Du Pont De Nemours & Company Cationic cyanato and thiocyanato complexes useful as radiodiagnostic agents
GB8723438D0 (en) * 1987-10-06 1987-11-11 Amersham Int Plc Cationic complexes of technetium-99m
JP3176489B2 (ja) * 1993-07-22 2001-06-18 中部電力株式会社 真空バルブ

Also Published As

Publication number Publication date
IL89779A0 (en) 1989-09-28
EP0337654B1 (en) 1996-02-07
CN1079746A (zh) 1993-12-22
ES2082771T3 (es) 1996-04-01
CA1336437C (en) 1995-07-25
EP0337654A3 (en) 1991-04-24
CN1031828C (zh) 1996-05-22
HK98097A (en) 1997-08-08
DE68925594D1 (de) 1996-03-21
US5045302A (en) 1991-09-03
KR900016237A (ko) 1990-11-13
IL89779A (en) 1995-01-24
JP2764037B2 (ja) 1998-06-11
JP2690142B2 (ja) 1997-12-10
DK163289D0 (da) 1989-04-05
DE68925594T2 (de) 1996-06-20
DK171416B1 (da) 1996-10-21
JPH0222286A (ja) 1990-01-25
KR0149439B1 (ko) 1998-10-15
EP0337654A2 (en) 1989-10-18
JPH09328495A (ja) 1997-12-22
DK163289A (da) 1989-10-12
CN1040373A (zh) 1990-03-14
ATE133956T1 (de) 1996-02-15
GB8808414D0 (en) 1988-05-11
CN1022633C (zh) 1993-11-03

Similar Documents

Publication Publication Date Title
TW206231B (https=)
US20220125959A1 (en) Prostate-specific membrane antigen (psma) inhibitors as diagnostic and radionuclide therapeutic agents
TW201034690A (en) Technetium-and rhenium-bis (heteroaryl) complexes and methods of use thereof for inhibiting PSMA
KR20190121824A (ko) 99m-Tc 표지 이소니트릴-함유 글루코스 유도체 및 그 제조방법과 용도
CN112209970B (zh) 一种锝-99m标记含异腈的谷氨酸-脲衍生物的制备方法和应用
CN109320557B (zh) 99mTc(CO)3核标记的含异腈的帕博西尼衍生物及制备方法和应用
EP0311352B1 (en) Cationic complexes of technetium-99m
Lin et al. Preparation and biodistribution of a 99mTc tricarbonyl complex with deoxyglucose dithiocarbamate as a tumor imaging agent for SPECT
Bolzati et al. Biological in vitro and in vivo studies of a series of new asymmetrical cationic [99mTc (N)(DTC-Ln)(PNP)]+ complex (DTC-Ln= alicyclic dithiocarbamate and PNP= diphosphinoamine)
NL8303481A (nl) Werkwijze voor het radio-afbeelden van het myocardium van zoogdieren onder gebruikmaking van radiogemerkte lipofiele kationen.
JPH11504002A (ja) 診断医薬品及び治療医薬品としての使用のためのヒドロキシアルキルホスフィン化合物並びにその製造方法
CA2276284C (en) Radioiodinated phospholipid ether analogs and methods of using the same
Rafik et al. Synthesis, X-ray analysis, and antiviral evaluation of allohimachalol: insights into stereoselectivity in epoxidation
EP0386873B1 (en) Cationic complexes of technetium 99m, and ligands therefor
Maresca et al. Novel ether-containing ligands as potential 99mtechnetium (I) heart agents
Wang et al. A study of the relationship between chemical structure and bone localization of Tc-99m diphosphonic acids: Concise communication
Pietzsch et al. Synthesis and autoradiographic evaluation of a novel high-affinity Tc-99m ligand for the 5-HT2A receptor
Wu et al. Synthesis and evaluation of [99mTc] TcAMD3465 as a SPECT tracer for CXCR4 receptor imaging
EP0291281A1 (en) Preparation of Tc-99m Radiopharmaceuticals
CA2840031A1 (en) New ligands for targeting of s1p receptors for in vivo imaging and treatment of diseases
CN105524113B (zh) 99mTcN核标记含三唑环的葡萄糖氨荒酸盐配合物及制备方法和应用
Liu et al. Synthesis and biological evaluation of novel 99mTc (CO) 3 labeled glucose derivatives prepared by click chemistry route
Lakshmi et al. (R)-N-Methyl-3-(3-125I-pyridin-2-yloxy)-3-phenylpropan-1-amine: a novel probe for norepinephrine transporters
CN101575355B (zh) 一种99mTc标记柔红霉素氨荒酸盐配合物及制备方法和应用
ES2547647T3 (es) Complejos de tricarbonilo con quelantes tridentados para la obtención de imágenes del miocardio